Applied DNA Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed Digital Asset Treasury Strategy

Reuters09-30

<a href="https://laohu8.com/S/APPDW">Applied DNA</a> Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed <a href="https://laohu8.com/S/DAAQU">Digital Asset</a> Treasury <a href="https://laohu8.com/S/MSTR">Strategy</a>

Applied DNA Sciences Inc. (NASDAQ: APDN), a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock (or prefunded warrants) and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. Lucid Capital Markets acted as the sole placement agent for the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied DNA Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929086912) on September 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2571352573?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 03:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571352573","market":"nz","top_or_hot":-1,"title":"Applied DNA Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed Digital Asset Treasury Strategy","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/APPDW\">Applied DNA</a> Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed <a href=\"https://laohu8.com/S/DAAQU\">Digital Asset</a> Treasury <a href=\"https://laohu8.com/S/MSTR\">Strategy</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/APDN\">Applied DNA Sciences Inc</a>. (NASDAQ: APDN), a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock (or prefunded warrants) and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. <a href=\"https://laohu8.com/S/LCID\">Lucid</a> Capital Markets acted as the sole placement agent for the transaction.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/AMAT\">Applied</a> DNA Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929086912) on September 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Applied DNA Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed Digital Asset Treasury Strategy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApplied DNA Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed Digital Asset Treasury Strategy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-30 03:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/APPDW\">Applied DNA</a> Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed <a href=\"https://laohu8.com/S/DAAQU\">Digital Asset</a> Treasury <a href=\"https://laohu8.com/S/MSTR\">Strategy</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/APDN\">Applied DNA Sciences Inc</a>. (NASDAQ: APDN), a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock (or prefunded warrants) and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. <a href=\"https://laohu8.com/S/LCID\">Lucid</a> Capital Markets acted as the sole placement agent for the transaction.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/AMAT\">Applied</a> DNA Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929086912) on September 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APDN","symbol_name":"Applied DNA Sciences","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL1L8YlN:1","article_id":"2571352573","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571352573","pubTimestamp":1759172896,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Applied DNA Sciences Inc. , a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock  and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. Lucid Capital Markets acted as the sole placement agent for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APDN":"Applied DNA Sciences","BK4121":"生命科学工具和服务","BK4583":"猴痘概念"},"translate_title":"Applied DNA Sciences宣布高达5800万美元的私募，以推出BNB支持的数字资产资金策略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APDN":0.9},"content_text":"Applied DNA Sciences Announces Up to $58 Million Private Placement to Launch BNB-Backed Digital Asset Treasury Strategy\n\n\nApplied DNA Sciences Inc. (NASDAQ: APDN), a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock (or prefunded warrants) and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. Lucid Capital Markets acted as the sole placement agent for the transaction.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied DNA Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250929086912) on September 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2571352573","isCrawlerRequest":true}